Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?

Suerbaum, 2002, Helicobacter pylori infection, N Engl J Med, 347, 175, 10.1056/NEJMra020542 Sipponen, 1983, Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma: comparison with a representative population sample, Cancer, 52, 1062, 10.1002/1097-0142(19830915)52:6<1062::AID-CNCR2820520622>3.0.CO;2-P Rokkas, 1991, Detection of an increased incidence of early gastric cancer in patients with intestinal type-metaplasia who are closely followed-up, Gut, 32, 1110, 10.1136/gut.32.10.1110 Li, 2016, Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study, Am J Gastroenterol, 111, 1104, 10.1038/ajg.2016.188 Kong, 2014, Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis, World J Gastroenterol, 20, 5903, 10.3748/wjg.v20.i19.5903 Eshmuratov, 2010, The correlation of endoscopic and histological diagnosis of gastric atrophy, Dig Dis Sci, 55, 1364, 10.1007/s10620-009-0891-4 Fuchs, 1993, Neopterin, biochemistry and clinical use as a marker for cellular immune reactions, Int Arch Allergy Immunol, 101, 1, 10.1159/000236491 Unal, 2009, Serum neopterin as a prognostic indicator in patients with gastric carcinoma, J Invest Surg, 22, 419, 10.3109/08941930903410783 Fox, 2000, Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter induced gastric atrophy, Nat Med, 6, 536, 10.1038/75015 Murr, 2002, Neopterin as a marker for immune system activation, Curr Drug Metab, 3, 175, 10.2174/1389200024605082 Dixon, 1996, Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Am J Surg Pathol, 20, 1161, 10.1097/00000478-199610000-00001 Werner, 1987, Determination of neopterin in serum and urine, Clin Chem, 33, 62, 10.1093/clinchem/33.1.62 Asaka, 2001, Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study, Helicobacter, 6, 294, 10.1046/j.1523-5378.2001.00042.x Correa, 2006, Etiopathogenesis of gastric cancer, Scand J Surg, 95, 218, 10.1177/145749690609500402 Sepulved, 2003, Improvement of gastric atrophy after cure of Helicobacter pylori. What we know, what we don’t know, and why care?, J Clin Gastroenterol, 36, 382, 10.1097/00004836-200305000-00002 Sánchez-Cuén, 2016, Regression of gastric intestinal metaplasia after the eradication of Helicobacter pylori infection in a hospital in Mexico, Rev Esp Enferm Dig, 12, 770 Blanchard, 1998, Immunological determinants that may affect the Helicobacter pylori cancer risk, Aliment Pharmacol Ther, 12, 83, 10.1111/j.1365-2036.1998.00010.x Rau, 2012, Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach, Am J Pathol, 181, 487, 10.1016/j.ajpath.2012.04.028 Maeda, 2001, Distinct mechanism of Helicobacter pylori-mediated NF-κB activation between gastric cancer cells and monocytic cells, J Biol Chem, 276, 44856, 10.1074/jbc.M105381200 Schroecksnadel, 2010, LPS-induced NF-κB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase, Biochem Biophys Res Commun, 399, 642, 10.1016/j.bbrc.2010.07.134 Jha, 2008, High immunoglobulin A seropositivity for combined Chlamydia pneumonia–Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker, Heart Vessels, 23, 390, 10.1007/s00380-008-1062-9 Chung, 2009, Comparison of the validity of three biomarkers for gastric cancer screening carcinoembryonic antigen pepsinogens, and high sensitive C-reactive protein, J Clin Gastroenterol, 43, 19, 10.1097/MCG.0b013e318135427c